InMed Announces Results of 2024 Annual General Meeting
Portfolio Pulse from
InMed Pharmaceuticals Inc. held its 2024 Annual General Meeting where shareholders voted on matters outlined in the company's notice of meeting. Approximately 39.83% of the company's shares were represented.
December 19, 2024 | 1:15 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
InMed Pharmaceuticals held its 2024 Annual General Meeting with 39.83% of shares represented. Shareholders voted on key matters.
The AGM is a routine event where shareholders vote on company matters. The participation rate was 39.83%, which is a typical turnout for such meetings. No specific outcomes or changes were highlighted, suggesting a neutral impact on the stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100